About the Engagement
Stenvall Skoeld acted as financial advisor to Tissuemed on its acquisition by Becton, Dickinson and Company (BD).
Tissuemed is based in Leeds, UK. The company’s lead product, Tissuepatch™, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions. The technology’s thin, flexible and transparent composition that is ready to use out of the package makes it ideally suited for a range of surgical sealant applications.